Bayer CEO Bill Anderson sat down with News Editor Steve Davies after speaking about sustainable agriculture with industry ...

Bayer CEO Bill Anderson takes the stage at the 2025 CNBC CEO Council Summit to talk to leaders about managing through ...

Fast forward to today, and to-date Bayer has paid more than $10 billion to plaintiffs in litigation claiming Roundup as the cause of their cancer. And per CEO Bill Anderson in a Wall Street ...

Georgia shields Bayer from Roundup lawsuits becoming the second state to do so as MAHA report soon to be released, David ...

Bayer is fighting to keep the popular agricultural herbicide Roundup available for farmers in the U.S., but warned it could ...

German pharmaceutical giant Bayer’s shares jumped 10.5% on the London Stock Exchange on Tuesday morning following the company experiencing higher demand for its new cancer and kidney drugs in the ...

Bayer on Tuesday posted a smaller decline in first-quarter adjusted earnings than investors had feared as strong prescription numbers for new drugs offset a drop in its seed businesses, boosting its ...

Bayer said on Tuesday that the U.S. Supreme Court could decide as early as next month whether it will hear the German company's request to sharply limit litigation that could run into the billions of ...

As a result of the “exceptional momentum” of the two drugs, according to CEO Bill Anderson, Bayer’s pharma sector posted a surprising 4.4% increase in revenue to 4.55 billion euros ($5.07 ...

Bayer is again asking the Supreme Court to weigh in on whether federal law concerning pesticide labeling preempts state law failure-to-warn claims. In the meantime, the company is promoting bills that ...